Specificity of antisera produced against mitomycin C

Area of Science:

• Biochemistry
• Immunology
• Analytical Chemistry

Background:

• Mitomycin C (MMC) is a crucial chemotherapy agent.
• Accurate quantification of MMC and its metabolites is essential for therapeutic drug monitoring and understanding drug degradation.
• Developing specific immunoassays is vital for precise measurement of MMC.

Purpose of the Study:

• To evaluate the specificity of antisera produced in rabbits for a mitomycin C (MMC) enzyme immunoassay.
• To assess the assay's ability to differentiate MMC from its analogs and degradation products.
• To validate the use of this immunoassay for quantifying MMC in biological or chemical samples.

Main Methods:

• Competitive inhibition experiments were conducted using various mitomycin analogs and degraded MMC preparations.
• Antiserum specificity was assessed by measuring immunoreactivity with structural variants of MMC.
• Quantification of degraded MMC was compared between the enzyme immunoassay and spectrophotometric methods.

Main Results:

• The antiserum demonstrated high specificity, with significantly decreased immunoreactivity towards mitomycin A and B.
• Porfiromycin and acetyl MMC (Ac-MMC) showed enhanced reactivity, indicating the antigen was likely MMC acylated at the aziridine ring's imino group.
• Enzyme immunoassay quantification of degraded MMC correlated well with spectrophotometric measurements, confirming minimal cross-reactivity with degradation products.

Conclusions:

• The developed enzyme immunoassay exhibits high specificity for mitomycin C.
• The assay can reliably distinguish MMC from its common analogs and degradation products.
• This immunoassay is suitable for accurate quantification of mitomycin C and its related compounds.